Skip to main content
Premium Trial:

Request an Annual Quote

TGen Wins $150K Grant for AML Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A researcher at the Translational Genomics Research Institute has received a $150,000 grant from the American Cancer Society to identify potential targets of value in fighting acute myeloid leukemia (AML).

James Bogenberger, a researcher in TGen's Leukemia Research Team, will use the three-year grant to fund studies that will identify therapeutic targets that sensitize AML to epigenetic therapies, TGen said on Wednesday.

AML is a malignancy in white blood cells that fight infections, and it is the most common and deadliest form of acute adult leukemia. Because AML is caused by a progression of multiple cellular processes, this TGen project will seek to identify targets that inhibit it in combination with drugs that are already approved by the Food and Drug Administration.

Bogenberger's research will search for genes that, when silenced, may be used to increase the potency of these available epigenetic therapies.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.